Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes

Current Medical Research and Opinion

Volumn 25, Issue 9, 2009, Pages 2223-2228

  Gentile, Vincenzo ^a   Antonini, Gabriele ^a   Bertozzi, Maria Antonella ^b   Dinelli, Nicola ^b   Rizzo, Cosimo ^c   Virmani, Mohamed Ashraf ^d   Koverech, Aleardo ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d Sigma Tau SpA   (Italy)

Author keywords

Diabetes; Erectile dysfunction; L arginine; Nicotinic acid; Propionyl L carnitine; Superoxide; Vardenafil

Indexed keywords

ARGININE; EZEREX; NICOTINIC ACID; NITRIC OXIDE; PHOSPHODIESTERASE V; PLACEBO; PROPIONYLCARNITINE; UNCLASSIFIED DRUG; VARDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OUTCOME ASSESSMENT; QUESTIONNAIRE; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM;

ARGININE; CARNITINE; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; ERECTILE DYSFUNCTION; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; NIACIN; PENILE ERECTION; PIPERAZINES; PLACEBOS; QUESTIONNAIRES; SULFONES; TREATMENT OUTCOME; TRIAZINES; VASODILATOR AGENTS;

EID: 69849093915     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903138416     Document Type: Article

References (26)

1. Bivalacqua TJ, Usta MF,Champion HC, et al. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003;24:17-37
2. Bivalacqua TJ, Champion HC, Usta MF, et al. Rho A/Rho- Kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci 2004;10:9121
3. Musicki B, Burnett AL. ENOS function and dysfunction in the penis. Exp Biol Med 2006; 231:154-165
4. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in heath and disease. Physiol Rev 2007;87:315-424 (Pubitemid 46217686)
5. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003;26:1589-1596
6. Bohlen HG, Hash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 1993;265:219-225
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820 (Pubitemid 34000785)
8. Riccioni C, Sarcinella R, Palermo G, et al. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II. Int Angiol 2008;27:253-259
9. Virmani A, Ali SF, Binienda ZK. Neuroprotective strategies in drug abuse-evoked encephalopathy. Ann N Y Acad Sci 2009. In press
10. Gur S, Kadowitz PJ, Trost L, et al. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum. J Urol 2007;178 (4 Pt 1):1543-1548 (Pubitemid 47368385)
11. Klinge E, Alaranta S, Sjöstrand NO. Pharmacological analysis of nicotinic relaxation of bovine retractor penis muscle. J Pharmacol Exp Ther 1988;245:280-286 (Pubitemid 18126641)
12. Lau DH, Mumtaz FH, Mikhailidis DP, et al. In vitro and in vivo effects of vardenafil (a PDE-5 inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits. Urol Int 2009;82:101-107
13. Corretti MC, Anderson TJ, Benijamin EJ, et al. Guidelines for the ultrasound-assessment of endothelial-dependent flowmediated vasodilation of the brachial artery. J Am Coll Cardiol 2002;39:257-265
14. Glantz SA. Primer of Biostatistics. New York: McGraw Hill
15. Kannel WB, McGee DL. Diabetes and cardiovascular diseases: the Framingham Study. JAMA 1979;241:2035-2038 (Pubitemid 9228506)
16. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1998;48:937-942
17. Kawano H, Motoyama T, Hirashimi O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34:146-154
18. Brodsky SV, Gao S, Li H, Goligorsky MS: hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol 2002;283:2130-2139 (Pubitemid 35217047)
19. Cerriello A, Mercuri F, Quagliaro L, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001;44:834-838 (Pubitemid 32642455)
20. Ceriello A, Quagliaro L, Catone B, et al. The role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002;25:1439-1443 (Pubitemid 41071158)
21. Cotter MA, Cameron NE, Keegan A, et al. Effect of acetyl and propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic heart. Diabetes Res Clin Pract 2001; 53:17-24
22. Rani PJ, Panneerselvam C. Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats. J Gerontol A Biol Sci Med Sci 2002;57:B134-7 (Pubitemid 34263289)
23. Savitha S, Tamilselvan J, Anusuyadevi M, et al. Oxidative stress on mitochondrial antioxidant defense system in the aging process: role of DL-α-lipoic acid and L-carnitine. Clin Chim Acta 2005;35:173-180 (Pubitemid 40501145)
24. Gigliano D, Martella R, Coppola L, et al. Vascular affects of acute hyperglycemia in humans are reversed by L-arginine evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997;95:1783-1790 (Pubitemid 27164394)
25. Offermanns S. The nicotinic acid receptor GPR109A (HM74A or PUMAG) as a new therapeutic target. Trends Pharmacol Sci 2007;27:384-390 (Pubitemid 43963187)
26. Kondoh N, Higuchi Y, Maruyama T, et al. Salvage therapy trial for erectile dysfunction using phosphodiesterase type 5 inhibitors and vitamin E: preliminary report. Aging Male 2008; 11:167-170